AwardedCzechiaGoodsCZK 189,778,000
Selektivní Imunosupresiva - Guselkumab I.
- Published
- Published 2 March 2026
- Deadline
- Closed 31 March 2026
Overview
Předmětem veřejné jsou dodávky léčivých přípravků pro subkutánní podání (s.c.) s obsahem monoklonální protilátky guselkumab (ATC skupina L04AC16) pro léčbu pacientů ve schválených indikacích dle SmPC a dle indikačního omezení úhrady platných ke dni podání nabídek.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 189,778,000
- Procedure
- Open
- Published
- 2 March 2026
- Deadline
- Closed
Immunosuppressive agents
Award outcome
- Awarded value
- CZK 119,921,000
- Award date
- 17 April 2026
- Contract period
- — → 27 March 2030
- Janssen-Cilag s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
19 May 2026
Contract Notice
2 March 2026
Contracting authority
Institut klinické a experimentální medicíny
Procuring entityPraha, Czechia
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.